The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Woody James N. since 2013.
This trader's CIK number is 1553355.
At the time of last reporting, Woody James N. was the Chief Executive Officer of 180 Life Sciences Corp.. (stock ticker symbol ATNF).
Also see all insider trading activities at 180 Life Sciences Corp..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2013 | TLOG | 261,427 | $1,829,989 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2013 | OMED | 88,235 | $1,499,995 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | ATNF | 40,000 | $41,200 | 0 | $0 | 0 | $0 |
| 2021 | ATNF | 12,500 | $53,374 | 0 | $0 | 0 | $0 |
| 2020 | ATNF | 1,000 | $3,290 | 0 | $0 | 0 | $0 |
1. Tetralogic Pharmaceuticals Corp (TLOG)
2. Oncomed Pharmaceuticals Inc (OMED)
3. 180 Life Sciences Corp. (ATNF)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2013-12-17 | TLOG | Buy | 261,427 | 7.00 | 1,829,989 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2013-07-23 | OMED | Buy | 88,235 | 17.00 | 1,499,995 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-05-18 | ATNF | Buy | 40,000 | 1.03 | 41,200 |
| 2021-12-09 | ATNF | Buy | 12,500 | 4.27 | 53,374 |
| 2020-11-09 | ATNF | Buy | 1,000 | 3.29 | 3,290 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Woody James N. (Chief Executive Officer of 180 Life Sciences Corp. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.